For example, METTL14 can induce sunitinib resistance in ccRCC by enhancing the stability of tumor necrosis factor receptor-associated factor 1 mRNA and promoting its expression [4]. This evidence concerns the gene METTL14 and nonpapillary renal cell carcinoma.